the psychiatryneurology.net – legal

Posted on August 1, 2012 by Maurice Preter MD

I created a new e-newspaper, the psychiatryneurology.net – legal, a digest of legal news related to medical tort, traumatic brain injury, psychological trauma and related topics. Looks beautiful. Hard not to love technology. Please subscribe. Link http://paper.li/DrMauricePreter/1343869858  

Posted in Events, Forensic Neuropsychiatry, News, Psychiatry/Neurology | Tagged , , , , |

Anti-inflammatory utility of Boswellia serrata (frankincense)

Posted on July 27, 2012 by Maurice Preter MD

Reading up on Boswellia serrata – this is a good starter article: http://www.altmedrev.com/publications/13/2/165.pdf “Boswellia serrata Description Boswellia serrata (frankincense) is a moderate-to-large branching tree (growing to a height of 12 feet) found in India, Northern Africa, and the Middle East. … Continue reading →

Posted in Aging, Health, new treatments | Tagged , , , , , |

A role for vitamin D in the treatment of multiple sclerosis (MS)

Posted on July 26, 2012 by Maurice Preter MD

This is such an important topic that I am posting the full-length article. On pubmed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882221/?tool=pubmed. Neurology. 2010 June 8; 74(23): 1852–1859. doi:  10.1212/WNL.0b013e3181e1cec2 PMCID: PMC2882221 A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis … Continue reading →

Posted in dietary, Health, metabolic, new treatments, Psychiatry/Neurology | Tagged , , , , |

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Posted on July 24, 2012 by Maurice Preter MD

================================================   Nutr Metab (Lond). 2009 Aug 10;6:31. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Source Accera, … Continue reading →

Posted in Aging, dietary, Health, metabolic, News, Psychiatry/Neurology | Tagged , , |

The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.

Posted on March 3, 2012 by Maurice Preter MD

Nutr J. 2011 Oct 20;10:117. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults. … Continue reading →

Posted in Aging, Health, metabolic, new treatments | Tagged , , |